CellCept (mycophenolate mofetil) - Feb 12, 2009

Audience: Renal, cardiac, and hepatic transplantation healthcare professionals

[Posted 02/12/2009] FDA and Roche Laboratories notified healthcare professionals of the introduction of a CellCept Medication Guide to provide important safety information in language that patients can easily comprehend. FDA regulations require a pharmacist to distribute a copy of the Medication Guide to every patient who fills a CellCept prescription from this point forward. FDA has also required the introduction of a Medication Guide for mycophenolic acid, marketed as Myfortic by Novartis.

[January 2009 - Dear Healthcare Provider Letter - Roche]
[January 2009 - Dear Pharmacist Letter - Roche]

Comments